Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996

CMAJ. Canadian Medical Association Journal

Volumn 170, Issue 10, 2004, Pages 1545-1549

  Ng, Edward ^a   Wilkins, Russell ^a,b   Fung, Michael Fung Kee ^b   Berthelot, Jean Marie ^a,c  

^a STATISTICS CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CAUSE OF DEATH; CONTROLLED STUDY; DEATH CERTIFICATE; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; POPULATION RESEARCH; URBAN AREA; UTERINE CERVIX CANCER;

EID: 2542433128     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1031528     Document Type: Article

References (41)

1. Health Canada. Proceedings of Interchange '95: a Canadian forum to collaborate on cervical cancer screening program implementation strategies. Ottawa: Health Canada; 1995. p. 7. Cat no H39-357/1995E.
2. Health Canada. Cervical cancer screening in Canada: 1998 surveillance report. Ottawa: Health Canada; 2002. p. ix, 8. Cat no H39-616/1998E.
3. National Cancer Institute of Canada. Canadian cancer statistics 2000. Toronto: The Institute; 2000.
4. Federal, Provincial and Territorial Advisory Committee on Population Health. Toward a healthy future: second report on the health of Canadians. Ottawa: The Committee; 1999. p. xv. Cat no H39-468/1999E.
5. Wilkins R, Berthelot JM, Ng E. Trends in mortality by neighbourhood income in urban Canada from 1971 to 1996. Health Rep 2002;13(Suppl):45-72.
6. International classification of diseases. 8th rev. Geneva: World Health Organization; 1969.
7. International classification of diseases. 9th rev. Geneva: World Health Organization; 1978.
8. Spiegelman M. Introduction to demography. Rev ed. Cambridge (MA): Harvard University Press; 1968. p. 111-4.
9. World Health Organization. The International Association of Cancer Registries cancer mortality database; 2001. Available: www-dep.iarc.fr/dataava/ infodata.htm (accessed 2004 Feb 12).
10. National Cancer Institute of Canada. Canadian cancer statistics 2002. Toronto: The Institute; 2002.
11. Miller AB. Planning cancer control strategies. Chronic Dis Can 1992;13(1):S1-40.
12. Health Canada. Cervical cancer in Canada: March 1998 cancer updates. Ottawa: Health Canada Cancer Bureau; 1998. p. 4.
13. Miller AB. The brave new world: What can we realistically expect to achieve through cancer control early in the new millennium? Chronic Dis Can 1999;20 (4):139-50.
14. Band PR, Gaudette LA, Hill GB, Holowaty EJ, Huchcroft SA, Johnston GM, et al. The making of the Canadian Cancer Registry: cancer incidence in Canada and its regions, 1969 to 1988. Ottawa: Minister of Supply and Services Canada; 1993. p. 52-3. Cat no C52-42/1992.
15. Gaudette LA, Altmayer CA, Wysocki M, Gao RN. Cancer incidence and mortality across Canada. Health Rep 1998;10(1):51-66.
16. Garceau S. Female preventive health practices. In: Rootman I, Warren R, Stephens T, Peters L, editors. Canada's Health Promotion Survey: technical report. Ottawa: Department of National Health and Welfare / Minister of Supply and Services Canada; 1988. p. 79-88. Cat no H39-119/1988E.
17. O'Connor A. Women's cancer prevention practices. In: Stephens T, Graham DF, editors. Canada's Health Promotion Survey 1990: technical report. Ottawa: Department of National Health and Welfare / Minister of Supply and Services Canada; 1993. p. 169-80. Catno H39-263/2-1990E.
18. Lee J, Parsons GF, Gentleman JF. Falling short of Pap test guidelines. Health Rep 1998;10(1):9-19.
19. Snider J, Beauvais J, Levy I, Villeneuve P, Pennock J. Trends in mammography and Pap smear utilization in Canada. Chronic Dis Can 1998;17(3-4):108-17.
20. Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA 1994;272(7):530-4.
21. Goel V. Factors associated with cervical cancer screening: results from the Ontario Health Survey. Can J Public Health 1994;85(2):125-7.
22. Maxwell CJ, Bancej CM, Snider J, Vik SA. Factors important in promoting cervical cancer screening among Canadian women: findings from the 1996-97 National Population Health Survey (NPHS). Can J Public Health 2001;92(2):127-33.
23. Gupta S, Roos LL, Walld R, Traverse D, Dahl M. Delivering equitable care: comparing preventive services in Manitoba. Am J Public Health 2003;93:2086-92.
24. Snider JA, Beauvais JE. Pap smear utilization in Canada: estimates after adjusting the eligible population for hysterectomy status. Chronic Dis Can 1998; 19(1):19-24.
25. Anttila A, Nieminen P. Cervical cancer screening programme in Finland. Eur J Cancer 2000;36(17):2209-14.
26. Sigurdsson K. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand 1999; 78(6):478-85.
27. Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999;318:904-8.
28. Schaffer P, Sancho-Garnier H, Fender M, Dellenbach P, Carbillet JP, Monnet E, et al. Cervical cancer screening in France. Eur J Cancer 2000;36(17): 2215-20.
29. Makuc DM, Fried VM, Parsons PE. Health insurance and cancer screening among women. Adv Data 1994;(254):1-2.
30. Gorey KM, Holowaty EJ, Fehringer G, Laukkanen E, Moskowitz A, Webster DJ, et al. An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas. Am J Public Health 1997;87(7): 1156-63.
31. Singh GK, Millar BA, Hankey BF, Edwards BK. Area socioecmomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999. NCI Cancer Surveillance Monograph ser no 4. Bethesda (MD): National Cancer Institute, National Institutes of Health, US Department of Health and Human Services; 2003. NIH publication no 03-5417.
32. Veugelers PJ, Yip AM, Kephart G. Proximate and contextual socioeconomic determinants of mortality: multilevel approaches in a setting with universal health care coverage. Am J Epidemiol 2001;154(8):725-32.
33. Mustard CA, Derksen S, Berthelot JM, Wolfson M. Assessing ecologic proxies for household income: a comparison of household and neighbourhood level income measures in the study of population health status. Health Place 1999;5:157-71.
34. World Health Organization. Targets for health for all. Copenhagen: World Health Organization Regional Office for Europe; 1985.
35. Luciani S, Berman NJ. Status report: Canadian strategy for cancer control. Chronic Dis Can 2000;21(1):21-5.
36. Lipskie T, Gibbons L, Whylie B, Bryant H, Ashbury FD. Knowledge, attitudes and behaviours concerning cancer screening in Canada. Chronic Dis Can 1997;18(4):176-8.
37. 7. Bosch FX, Lorincz A, Muñoz N, Meijer CJL, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55(4):244-65.
38. Sherman ME, Schiffman M, Cox JT. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94(2):102-7.
39. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287(16):2120-9.
40. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347(21):1645-51.
41. Crum CP. The beginning of the end for cervical cancer? N Engl J Med 2002; 347(21):1703-6.